Sequential combination therapy

Details Sequential combination therapy Sequential combination therapy

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/455 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2666714

Disclosed are new methods for treatment of angiogenesis-related disorders. Angiogenesis-related disorders are treated by administration of a Tie1 ectodomain-binding agent and a VEGF antagonist agent.

La présente invention concerne de nouveaux procédés destinés au traitement de troubles liés à l'angiogenèse. Lesdits troubles liés à l'angiogenèse sont traités par l'administration d'un agent de liaison ectodomaine Tie1 et d'un agent antagoniste VEGF.

Affiliated with

Also associated with

Rating

Sequential combination therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sequential combination therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sequential combination therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1342460